Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adipocyte differentiation pathways describe the complex network of signaling cascades and transcriptional programs that mediate the process by which mesenchymal stem cells become mature adipocytes. Essential steps include two phases: the commitment phase (where stem cells are restricted to the adipocyte lineage) and the differentiation phase (where preadipocytes undergo mitotic expansion and subsequent morphological changes, culminating in lipid accumulation). Key molecules include transcription factors such as PPARγ (the master regulator), CCAAT/enhancer-binding proteins (C/EBPs), and other families like Kruppel-like factors (KLFs). Pathways such as PI3K-Akt, MAPK, Hedgehog, Notch, TGF-β, Wnt, and insulin signaling can promote or inhibit the differentiation process, and epigenetic modification (e.g., DNA methylation) may also play a critical role. These pathways are implicated in metabolic health and diseases like obesity, diabetes, and cancer, and are of interest for therapeutic interventions. This entry does not correspond to a single molecular entity but encompasses a broad set of mechanisms and molecules; individual targets within these pathways (such as PPARγ or C/EBPα) are potential canonical therapeutic targets.
Activation of PPARγ (a master regulator nuclear receptor promotes adipocyte gene expression); Modulation of C/EBP family transcription factors (controls gene expression relevant to adipogenesis); Inhibition or activation of signaling cascades such as PI3K-Akt, Wnt, TGF-β, Hedgehog, MAPK
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adipocyte differentiation pathways.